Condensed Consolidated Balance Sheets - USD ($)	Jun. 30, 2023	Dec. 31, 2022
Current assets
Cash and cash equivalents	$ 13,329,101	$ 34,669,605
Other receivables	572,466	1,703,160
Prepaid expenses	8,069,622	6,665,988
Other current assets	272,100	0
Total current assets	22,243,289	43,038,753
Property and equipment, net	45,785	64,908
Other non-current assets	920,880	722,722
Total assets	23,209,954	43,826,383
Current liabilities
Accounts payable	6,541,115	2,027,953
Accrued expenses	4,193,799	10,894,016
Deferred grant funding	13,694,085	18,303,567
Current portion of lease liabilities	271,825	398,391
Total current liabilities	24,700,824	31,623,927
Deferred revenue	1,205,206	1,000,000
Lease liabilities long-term	23,326	90,346
Total liabilities	25,929,356	32,714,273
Commitments and contingencies (Note 7)
Stockholders' equity (deficit)
Preferred stock, $0.01 par value, 5,000,000 shares authorized; None issued and outstanding	0	0
Common stock, $0.0001 par value; 240,000,000 shares authorized; 86,633,588 and 84,825,481 shares issued and outstanding at June 30, 2023 and December 31, 2022, respectively	8,663	8,482
Accumulated other comprehensive loss	(404,467)	(351,311)
Additional paid-in capital	155,555,775	152,529,579
Accumulated deficit	(157,879,373)	(141,074,640)
Total stockholders' equity (deficit)	(2,719,402)	11,112,110
Total liabilities and stockholders' equity (deficit)	$ 23,209,954	$ 43,826,383

Deferred Grant Funding Current

No definition available.

Name:	dare_DeferredGrantFundingCurrent
Namespace Prefix:	dare_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	instant

- Definition

Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).